← Leaderboards
Mark A Munger
University Of Utah
$113,137
Attributed
$113,137
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $66.8K · FY2005–08$100K$75K$50K$25K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$113,137 · 5
By mechanism
M01$113,137 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Donald E Kohan$13,467,488
- E Michael Gilbert$384,445
- Susan P Ethridge$251,336
- Peter A. Beal$14,660,461
- Marta Szulik$245,485
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHeart FailureBlood PressureHeart Disorder ChemotherapyHeart FunctionHeart RateHuman Therapy EvaluationCardiovascular Disorder ChemotherapyBlood SpecimenAffectComputer Retrieval Of Information On Scientific Projects DatabaseDiastolic Blood PressureDoseClassEssential HypertensionChronicEnrollmentEndopeptidasesFunctional ImprovementFundingGrantCarvedilolAdrenergic Receptor
Grant awards (8)
CARVEDILOL TREATMENT FOR CHRONIC HEART FAILURE$1,461
M01 · FY2008 · RR · contact PI
CARVEDILOL TREATMENT FOR CHRONIC HEART FAILURE$66,802
M01 · FY2007 · RR · contact PI
LEFT VENTRICULAR SYSTOLIC AND/OR DIASTOLIC DYSFUNCTION$22,652
M01 · FY2005 · RR
Left ventricular systolic and/or diastolic dysfunction$15,726
M01 · FY2004 · RR
MISOPROSTOL EFFECTS ON BLOOD PRESSURE CHANGES IN ESSENTIAL HYPERTENSION$1,624
M01 · FY2001 · RR
SAFETY OF BMS 186716 IN THE TREATMENT OF HEART FAILURE$1,624
M01 · FY2001 · RR
MISOPROSTOL EFFECTS ON BLOOD PRESSURE CHANGES IN ESSENTIAL HYPERTENSION$1,624
M01 · FY2000 · RR
SAFETY OF BMS 186716 IN THE TREATMENT OF HEART FAILURE$1,624
M01 · FY2000 · RR